Business Wire

ADANI-GROUP

Share
International Rating Agencies Affirm Rating With Upgraded “Stable” Outlook for Various Adani Portfolio Companies

International Rating agencies Moody’s (vide press release dated 13th February 2024) and S&P (vide press release dated 22nd January 2024) have affirmed and upgraded the outlook to “stable” for all the issuances for Adani complex issued in the international market by various Adani Portfolio companies.

This assures high credit quality with stable and predictable cashflows across all issuers of Adani complex. Adani Portfolio has the largest number of Investment Grade (BBB-/Baa3 and higher) rated issuances out of private companies in India and equivalent to India’s sovereign rating.

Additionally, Moody’s vide its press release dated 13th February 2024 stated that “the Group has completed a number of debt transactions, including refinancing as well as obtaining new loan facilities, demonstrating its continued access to debt capital at a reasonable cost. At the same time, several high-profile equity transactions by large institutional and strategic investors, such as GQG and Qatar Investment Authority, also demonstrated the Group's continued equity market access.

“[W]hilst an investigation by Securities and Exchange Board of India (SEBI) – India's securities market regulator - is still ongoing, the Supreme Court's decision to entrust SEBI to complete the investigation on the Adani Group and the court's view that there is no apparent regulatory failure attributable to SEBI have curbed the potential tail risk in a downside scenario.”

And S&P vide its press release dated 22nd January 2024 noted that “We believe the conclusion of most regulatory investigations into the Adani Group without evidence of wrongdoing has reduced downside risk.

“Repayment of all promoter loans linked to share prices, equity, and bank loans raised by multiple group entities at competitive rates reflects restored access to funding. In our view, rated entities Adani Electricity Mumbai Ltd. (AEML) and Adani Ports and Special Economic Zone Ltd. (APSEZ) enjoy good competitive positions, healthy cash flows, and adequate liquidity to meet their debt-servicing requirements.”

A summary of the rating upgrades is as detailed below -

Issuer Name

Rating

Agency

Summary of Rating Action

Rating

Outlook

Adani Ports and SEZ Limited

S&P

Reaffirmed at BBB-

Upgraded to ‘Stable’ from ‘Negative’

Moody’s

Reaffirmed at Baa3

Reaffirmed at ‘Stable’

Fitch

Maintained at BBB-

Maintained at ‘Stable’

Adani International Container Terminal Private Limited

S&P

Maintained at BBB-

Maintained at ‘Stable’

Moody’s

Reaffirmed at Baa3

Reaffirmed at ‘Stable’

Fitch

Maintained at BBB-

Maintained at ‘Stable’

Adani Electricity Mumbai Limited (subsidiary of AESL)

S&P

Reaffirmed at BBB-

Upgraded to ‘Stable’ from ‘Negative’

Moody’s

Reaffirmed at Baa3

Upgraded to ‘Stable’ from ‘Negative’

Fitch

Maintained at BBB-

Maintained at ‘Stable’

Adani Transmission Step One Limited (subsidiary of AESL)

Moody’s

Reaffirmed at Baa3

Upgraded to ‘Stable’ from ‘Negative’

Fitch

Maintained at BBB-

Maintained at ‘Stable’

Adani Energy Solutions Limited Restricted Group 1 – AESL RG1

Moody’s

Reaffirmed at Baa3

Reaffirmed at ‘Stable’

Fitch

Maintained at BBB-

Maintained at ‘Stable’

Adani Green Energy Limited

Moody’s

Reaffirmed at Ba3

Upgraded to ‘Stable’ from ‘Negative’

Adani Green Energy Limited – RG1

S&P

Maintained at BB-

Maintained at ‘Stable’

Moody’s

Reaffirmed at Ba2

Upgraded to ‘Stable’ from ‘Negative’

Fitch

Maintained at BB+

Maintained at ‘Stable’

Adani Green Energy Limited – RG2

S&P

Maintained at BB+

Maintained at ‘Stable’

Moody’s

Reaffirmed at Ba1

Reaffirmed at ‘Stable’

Fitch

Maintained at BBB-

Maintained at ‘Stable’

(AESL: Adani Energy Solutions Limited)

The rating actions by both S&P and Moody’s now follows the same outlook that Fitch had reaffirmed as part of their review confirmed in CY2023 and all the international rating agencies now reflects the “Stable” outlook for all issuers within Adani universe.

Detailed press release of both agencies can be accessed through the following links.

Moody’s - https://www.moodys.com/research/Moodys-takes-rating-actions-on-8-Adani-Group-entities-Rating-Action--PR_485736

S&P - https://disclosure.spglobal.com/ratings/en/regulatory/article/-/view/type/HTML/id/3114891

About Adani Portfolio

Headquartered in Ahmedabad, the Adani Portfolio is the largest and fastest-growing portfolio of diversified businesses in India with interests in logistics (seaports, airports, shipping and rail), resources, power generation and distribution, renewable energy, gas and infrastructure, agro (commodities, edible oil, food products, cold storage and grain silos), real estate, public transport infrastructure, consumer finance, defence, and other sectors. Adani owes its success and leadership position to its core philosophy of ‘Nation Building’ and ‘Growth with Goodness’, a guiding principle for sustainable growth. The Portfolio is committed to protecting the environment and improving communities through its CSR programmes based on the principles of sustainability, diversity, and shared values.

Further information at www.adani.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240215968671/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release

Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release

52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society

Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release

- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and

Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release

The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p

Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release

‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye